Unicycive Therapeutics Ownership | Who Owns Unicycive Therapeutics?

Unicycive Therapeutics Ownership Summary

Unicycive Therapeutics is owned by 31.17% institutional investors, 2.93% insiders, and 65.90% retail investors. Nantahala capital management is the largest institutional shareholder, holding 5.20% of UNCY shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 4.24% of its assets in Unicycive Therapeutics shares.

UNCY Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Unicycive Therapeutics	31.17%	2.93%	65.90%
Sector	Healthcare Stocks	232.01%	10.74%	-142.75%
Industry	Biotech Stocks	381.47%	10.55%	-292.02%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Nantahala capital management	939.20K	5.20%	$5.42M
Vanguard group	788.59K	4.37%	$4.55M
Geode capital management	171.29K	0.95%	$989.21K
Bnp paribas arbitrage, snc	99.74K	0.55%	$575.51K
Morgan stanley	46.58K	0.26%	$268.79K
Blackrock funding, inc. /de	36.35K	0.20%	$209.77K
Blackrock	51.84K	0.15%	$25.98K
Chicago partners investment group	22.41K	0.12%	$155.10K
Ubs group	19.91K	0.11%	$114.85K
Sbi securities	558.00	0.00%	$3.22K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Nantahala capital management	939.20K	0.18%	$5.42M
Chicago partners investment group	22.41K	0.00%	$155.10K
Bnp paribas arbitrage, snc	99.74K	0.00%	$575.51K
Tfc financial management	300.00	0.00%	$1.73K
Sbi securities	558.00	0.00%	$3.22K
Geode capital management	171.29K	0.00%	$989.21K
Vanguard group	788.59K	0.00%	$4.55M
Tower research capital llc (trc)	-	-	-
Blackrock	51.84K	-	$25.98K
Silverarc capital management	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Vanguard group	788.59K	0.00%	129.71K
Bnp paribas arbitrage, snc	99.74K	0.00%	99.69K
Blackrock	51.84K	-	51.84K
Geode capital management	171.29K	0.00%	45.56K
Morgan stanley	46.58K	-	35.97K

Top Sellers

Holder	Shares	% Assets	Change
Vivo capital	-	-	-11.37M
Great point partners	-	-	-10.98M
Octagon capital advisors lp	-	-	-10.00M
Logos global management lp	-	-	-5.08M
Walleye capital	-	-	-4.09M

New Positions

Holder	Shares	% Assets	Change	Value
Blackrock	51.84K	-	51.84K	$25.98K
Bank of america corp /de/	223.00	-	223.00	$112.00

Sold Out

Holder	Change
Fortitude family office	-107.00
Jpmorgan chase	-184.00
Wells fargo & company/mn	-196.00
Soa wealth advisors, llc.	-1.00K
Redwood wealth management group	-3.00K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	29	-3.33%	5,630,293	-10.43%	31	2.57%	11	-52.17%	5	400.00%
Sep 30, 2025	30	66.67%	6,285,927	22.20%	34	1.99%	24	380.00%	1	-92.31%
Jun 30, 2025	18	-37.93%	5,144,082	-91.42%	41	1.59%	5	-64.29%	13	62.50%
Mar 31, 2025	4	-87.10%	21,301,904	-65.48%	3	0.07%	1	-95.24%	2	-60.00%
Dec 31, 2024	30	7.14%	61,690,744	31.86%	69	2.51%	20	-9.09%	5	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	511.73K	4.24%	43.67K
Vanguard Institutional Extnd Mkt Idx Tr	192.92K	1.60%	-
Fidelity Extended Market Index	87.56K	0.73%	30.95K
Blackrock Extended Mkt Fund CF	35.34K	0.29%	35.34K
Extended Equity Market Fund K	30.31K	0.25%	20.00
Fidelity Total Market Index	26.98K	0.22%	8.58K
Spartan Extended Market Index Pool F	19.73K	0.16%	127.00
NT Ext Equity Mkt Idx Fd - L	19.37K	0.16%	5.75K
Vanguard Instl Ttl Stck Mkt Idx Tr	16.66K	0.14%	-
Fidelity Series Total Market Index	16.06K	0.13%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 16, 2022	Schiller Brigitte		Buy	$12.38K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	-
2025 Q1	-	-
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	-	-

UNCY Ownership FAQ

Who Owns Unicycive Therapeutics?

Unicycive Therapeutics shareholders are primarily institutional investors at 31.17%, followed by 2.93% insiders and 65.90% retail investors. The average institutional ownership in Unicycive Therapeutics's industry, Biotech Stocks , is 381.47%, which Unicycive Therapeutics falls below.

Who owns the most shares of Unicycive Therapeutics?

Unicycive Therapeutics’s largest shareholders are Nantahala capital management (939.2K shares, 5.20%), Vanguard group (788.59K shares, 4.37%), and Geode capital management (171.29K shares, 0.95%). Together, they hold 10.51% of Unicycive Therapeutics’s total shares outstanding.

Does Blackrock own Unicycive Therapeutics?

Yes, BlackRock owns 0.15% of Unicycive Therapeutics, totaling 51.84K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 25.98K$. In the last quarter, BlackRock increased its holdings by 51.84K shares, a 100.00% change.

Who is Unicycive Therapeutics’s biggest shareholder by percentage of total assets invested?

Nantahala capital management is Unicycive Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.18% of its assets in 939.2K Unicycive Therapeutics shares, valued at 5.42M$.

Who is the top mutual fund holder of Unicycive Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Unicycive Therapeutics shares, with 4.24% of its total shares outstanding invested in 511.73K Unicycive Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools